Showing 141-150 of 3001 results for "".
Multiple Sclerosis Minute: Telemedicine and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-telemedicine-and-multiple-sclerosis/30116/Telemedicine is acceptable to patients and clinicians in the continuum of clinic-to-in-home care and reduces barriers to care.November/December 2015 Case Challenge: A 70-Year-Old Man with a Sudden Lisp
https://practicalneurology.com/diseases-diagnoses/neuromuscular/novemberdecember-2015-case-challenge-a-70-year-o/31086/By Mohanad Alzubaidi, MD and Aziz Shaibani, MD, FACP, FAAN, FANA A 70-year-old man presented with a six-month history of a "lisp," noted by his friends, that got worse the more he spoke. There was no diplopia, ptosis, dysphagia, muscle wasting, or extremities weakness. Since he was stresseMultiple Sclerosis Misdiagnosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-misdiagnosis/30123/Accurate diagnosis requires correspondence to typical clinical syndromes, correct interpretation of radiologic and CSF data, and thorough evaluation for mimics.Deepening Our Understanding of the Science Behind Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/deepening-our-understanding-of-the-science-behind-multiple-sclerosis/30207/- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31295/Management of Acute Seizures and Long-Term Antiepileptic Therapy: A Case StudyIn a recent article by Niranjan Siva, MD, and Amit Verma, MD, published in *Practical Neurology*, a 24-year-old male experienced two first-time generalized tonic-clonic seizures without aura within a two-hour period. Initi
Filling the Gaps in the Multiple Sclerosis Treatment Landscape
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/filling-the-gaps-in-the-multiple-sclerosis-treatment-landscape/30372/The addition of a potential breakthrough agent may change the treatment arena, but wellness and early treatment remain the foundation of effective care.Clarifying the Role of Vitamin D in Multiple Sclerosis Risk and Prevention
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/clarifying-the-role-of-vitamin-d-in-multiple-sclerosis-risk-and-prevention/30314/Recent findings reinforce the link between vitamin D levels and risk of multiple sclerosis.Disease Awareness: Multiple Sclerosis and Parkinson's
https://practicalneurology.com/columns/practice-management/disease-awareness-multiple-sclerosis-and-parkinsons/30781/The Multiple Sclerosis Prodrome: Past, Present, and Future
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-multiple-sclerosis-prodrome-past-present-and-future/31973/Multiple sclerosis may cause symptoms and disability prior to classically defined disease onset.RENEU (A Study to Evaluate the Safety, Effectiveness, and Tolerability of Gomekli in Children Aged ≥2 Years and Adults with an Inoperable NF1-PN; NCT03962543)
https://practicalneurology.com/programs/practical-neurology/trials-in-2/35433/Christopher Moertel, MD, Medical Director of the Pediatric Neuro-Oncology and Neurofibromatosis Programs at the University of Minnesota provides an overview of the ReNeu clinical trial which evaluated the safety, effectiveness, and tolerability of Gomekli in children aged ≥2 years and adults.